Search

everythinglearnresearchcommunity

for

Search:↓

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Microneedling with triamcinolone is a safe, effective, and less painful treatment for alopecia areata.

Oral isotretinoin is the most effective treatment for folliculitis decalvans.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Asynchronous telemedicine for acne treatment is effective and improves access and productivity.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Upadacitinib may effectively treat alopecia areata without side effects.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

ALA-photodynamic therapy helps reduce acne by causing acne cell death and lowering certain skin protein levels.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.